EUMCA News 

Akanda to Acquire Portugal-based Holigen, Securing a Cannabis Sector Leadership Position in Europe, the Middle East and Africa (EMEA) with EU GMP Market Access     Transformational deal will add prized cultivation, manufacturing and distribution assets to...

Clever Leaves Holdings Begins Sales of Cannabis Extracts in Germany Through Ethypharm Partnership Products imported and to be commercially available in Germanpharmacies BOCA RATON, Fla., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc.(NASDAQ: CLVR,...

An in-depth look at medical cannabis from EUMCA Chairman Professor Trevor Jones For many centuries, nature’s pharmacy has been an important source of potent therapeutic agents; either by administering parts of plants, eg opium and senna pods, or preparing...

Professor Trevor Jones CBE FMedSci, says: “CBD is NOT a narcotic.  The uncertainty about the legal status CBD, especially of plant-derived CBD, is a barrier to its medical use.” Professor Trevor Jones, Chair of the EUMCA urges the Commission to agree to the WHO...

Founding member of the EUMCA Tilray has reported that a clinical trial on its GMP medicinal cannabis product shows promise of reducing nausea and vomiting caused by chemotherapy. The results, published in the Annals of Oncology, found a significant improvement in the...

License marks commencement of European cultivation activities and establishes Portugal as Clever Leaves’ European medical cannabis production hub New York, Lisbon, August 25, 2020 – Clever Leaves (the “Company”), a leading multi-national operator and licensed producer...